Literature DB >> 20008830

Costs of dialysis--a regional population-based analysis.

Andrea Icks1, Burkhard Haastert, Afschin Gandjour, Nadja Chernyak, Wolfgang Rathmann, Guido Giani, Lars-Christian Rump, Rudolf Trapp, Michael Koch.   

Abstract

BACKGROUND: Population-based estimates of costs of renal replacement therapy are scarce in the literature. The aim of our study was to calculate the costs of long-term dialysis in 2006 on the basis of patient-specific data from a well-defined population in a region in western Germany (n = 310,757).
METHODS: Cost estimation was performed from the perspective of the statutory health insurance. All dialysis patients from the study region (n = 344, 54% male, mean age (+/-SD) 69 +/- 13 years, 42% diabetic) were assessed for the costs of the dialysis procedures, dialysis-related hospital admissions, outpatient contacts outside of our dialysis center, dialysis-related medication, patient transportation and related costs (e.g. reimbursement fees on the basis of the German diagnosis-related group system, price scales). We estimated the cumulative cost per patient year in 2006 (in Euros), along with the 10th and 90th percentiles and the 95% confidence intervals (CI) by using bootstrapping procedures.
RESULTS: The mean total dialysis-related cost in 2006 was 54,777 Euros (95% CI, 51,445-65,705) per patient year. The largest part of the costs (55%) was caused by the dialysis procedures, followed by the costs of medication (22%), hospitalization (14%) and transportation (8%). The total cost increased significantly with increasing age. No significant association was found between total cost and sex, dialysis strategy, end-stage renal disease duration and diabetes.
CONCLUSIONS: We present for the first time a cost estimation of dialysis in Germany on the basis of patient-level data in a population-based sample. Except age, patient characteristics were not significantly associated with costs. The largest part of the costs was caused by the dialysis procedures themselves; however, other dialysis-specific health care utilization also strongly contributed to the total cost.

Entities:  

Mesh:

Year:  2009        PMID: 20008830     DOI: 10.1093/ndt/gfp672

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  25 in total

1.  Economic burden of repeat renal surgery on solitary kidney--do the ends justify the means? A cost analysis.

Authors:  Nnenaya Q Agochukwu; Adam R Metwalli; Alexander Kutikov; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2012-09-19       Impact factor: 7.450

2.  Cumulative cost of prescription medication in outpatients with type 1 diabetes in Finland.

Authors:  R Lithovius; V Harjutsalo; C Forsblom; P H Groop
Journal:  Diabetologia       Date:  2010-12-07       Impact factor: 10.122

3.  The Effect of Risk of Maturation Failure and Access Type on Arteriovenous Access-Related Costs among Hemodialysis Patients.

Authors:  Sarah D Kosa; Amiram Gafni; Lehana Thabane; Charmaine E Lok
Journal:  Kidney360       Date:  2020-03-13

4.  A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events.

Authors:  Anne-Line Couillerot-Peyrondet; Cléa Sambuc; Yoël Sainsaulieu; Cécile Couchoud; Isabelle Bongiovanni-Delarozière
Journal:  Eur J Health Econ       Date:  2016-05-05

5.  Incidence and relative risk of renal replacement therapy in people with and without diabetes between 2002 and 2016 in a German region.

Authors:  Maria Narres; Heiner Claessen; Tatjana Kvitkina; Michael Koch; Lars Christian Rump; Thomas Weinreich; Andrea Icks
Journal:  Diabetologia       Date:  2019-12-21       Impact factor: 10.122

6.  Renal Replacement Therapy in People With and Without Diabetes in Germany, 2010-2016: An Analysis of More Than 25 Million Inhabitants.

Authors:  Heiner Claessen; Maria Narres; Tatjana Kvitkina; Adrian Wilk; Heiko Friedel; Christian Günster; Falk Hoffmann; Michael Koch; Karin Jandeleit-Dahm; Andrea Icks
Journal:  Diabetes Care       Date:  2021-05-04       Impact factor: 17.152

7.  Economics of dialysis dependence following renal replacement therapy for critically ill acute kidney injury patients.

Authors:  Olivier Ethgen; Antoine G Schneider; Sean M Bagshaw; Rinaldo Bellomo; John A Kellum
Journal:  Nephrol Dial Transplant       Date:  2014-10-17       Impact factor: 5.992

8.  Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.

Authors:  Jonas K Eriksson; Martin Neovius; Stefan H Jacobson; Carl-Gustaf Elinder; Britta Hylander
Journal:  BMJ Open       Date:  2016-10-07       Impact factor: 2.692

9.  High cost and low survival rate in high comorbidity incident elderly hemodialysis patients.

Authors:  Yi-Ting Lin; Ping-Hsun Wu; Mei-Chuan Kuo; Ming-Yen Lin; Tzu-Chi Lee; Yi-Wen Chiu; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

Review 10.  The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic Review.

Authors:  Maria Narres; Heiner Claessen; Sigrid Droste; Tatjana Kvitkina; Michael Koch; Oliver Kuss; Andrea Icks
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.